Section Arrow
RNAC.NASDAQ
- Cartesian Therapeutics
Quotes are at least 15-min delayed:2026/04/20 10:36 EDT
Regular Hours
Last
 6.9
-0.14 (-1.99%)
Day High 
7.15 
Prev. Close
7.04 
1-M High
7.2397 
Volume 
54.59K 
Bid
6.87
Ask
6.95
Day Low
6.79 
Open
7.03 
1-M Low
5.6 
Market Cap 
186.62M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 6.25 
20-SMA 6.23 
50-SMA 6.82 
52-W High 15.57 
52-W Low 5.6 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-5.02/-2.88
Enterprise Value
195.15M
Balance Sheet
Book Value Per Share
-4.76
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
2.80M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TOVXTheriva Biologics Inc0.4564+0.1992+77.45%0.09PE
ENVBEnveric Biosciences Inc.4.2601+2.4401+134.07%0PE
CMNDClearmind Medicine Inc.1.18+0.4604+63.98%-- 
ATAIAtaiBeckley Inc5.12+1.09+27.05%-- 
OCGNOcugen1.83-0.16-8.04%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.